tickrz reports
Vertex Pharmaceuticals Inc (VRTX)
Healthcare | Drugs
155.70  -1.41%
VRTX vs DRUGS SECTOR & S&P 500
VALUATION
VRTXSECTORS&P 500
P/E RATIO201.9240.521.12
EV/EBITDA RATIO2092.98133.412.66
P/S RATIO17.226.52.25
P/B RATIO22.077.73.45
QUALITY
RETURN ON EQUITY-0.72%15.79%13.64%
RETURN ON CAPITAL-3.92%19.38%10.09%
NET MARGIN-6.58%14.46%9.73%
DIVIDEND ANALYSIS
DIVIDEND YIELD
0%
PAYOUT RATION/A
3 YR DIVIDEND GROWTHN/A
FINANCIAL STRENGTH
PIOTROSKI F SCORE
5 OUT OF 9
DEBT-TO-EQUITY2%
INTEREST COVERAGE4.7x
CURRENT RATIO3.28
GROWTH
5 YR EPS GROWTH-226.86%
5 YR SPS GROWTH3.83%
5 YR BPS GROWTH4.38%
Vertex Pharmaceuticals Inc Filings

Annual & Quarterly Reports

Events or Changes Between Quarters (8-K)


Changes in Ownership